Assignment of Assignor's Interest

Recorded: 2021-02-13 Pages: 5

Assignor

DAHL, RUSSELL, DR

Executed: 2021-02-13

Assignee

NEURODON CORPORATION

9800 CONNECTICUT DRIVE, CROWN POINT, INDIANA, 46307

Covered Properties (7)

Quinoline Derivatives and Their Use for Treating Endoplasmic Reticulum Stress-Related Diseases and Disorders

Patent: 10,383,867 →

Application: 15/361,482 →

Publication: US 2017/0151225

Quinoline Containing Compounds and Their Use for Treating Endoplasmic Reticulum Stress-Related Diseases

Patent: 10,383,868 →

Application: 15/361,485 →

Publication: US 2017/0231973

Quinolines That Modulate Serca and Their Use for Treating Disease

Patent: 10,772,881 →

Application: 16/258,060 →

Publication: US 2019/0151303

Quinoline Alkenes as Cytoprotective Agents

Patent: 10,800,766 →

Application: 16/436,843 →

Publication: US 2019/0375737

Quinoline Oxadiazoles as Cytoprotective Agents

Patent: 10,793,558 →

Application: 16/436,846 →

Publication: US 2019/0375741

Quinolines as Cytoprotective Agents

Patent: 10,730,839 →

Application: 16/443,891 →

Publication: US 2019/0330156

Quinoxalines Useful as Cytoprotective Agents

Patent: 10,730,843 →

Application: 16/446,644 →

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.